Immunotherapy for invasive Candida infections: Translating host-directed strategies into clinical practice.
BACKGROUND Candida infections are a leading cause of invasive fungal disease (IFD), especially among critically ill and immunocompromised patients. Despite available pathogen-directed antifungal therapies, outcomes remain unsatisfactory with high associated morbidity and mortality rates. Increasing recognition of immun...